Stockreport

Agenus gains after updating early-stage cancer drug data [Seeking Alpha]

Ligand Pharmaceuticals Incorporated  (LGND) 
Last ligand pharmaceuticals incorporated earnings: 2/6 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.ligand.com
PDF therapy, botensilimab plus balstilimab (BOT/BAL), developed in partnership with Ligand Pharmaceuticals ( NASDAQ: LGND The analysis was based on 77 patients with relaps [Read more]